Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Archives of Neurology

• Publication date

  2000-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHNEUR.57.4.470PMID 10768619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

  2005cited by this paper
• Functional effects of striatal dysfunction in Parkinson disease.

  1997cited by this paper
• PET and the investigation of dementia in the parkinsonian patient.

  1997cited by this paper
• [18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.

  1997cited by this paper
• Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

  1996cited by this paper
• Historical review of research on functions of basal ganglia.

  1996cited by this paper
• Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.

  1996cited by this paper
• Attention related performance in two cognitively different subgroups of patients with multiple sclerosis.

  1995cited by this paper
• Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease

  1995cited by this paper
• Striatal dopamine transporter in different disability stages of Parkinson's disease studied with [(123)I]beta-CIT SPECT.

  1995cited by this paper
• Automatic and controlled information processing in multiple sclerosis.

  1994cited by this paper
• The behavioural and motor consequences of focal lesions of the basal ganglia in man.

  1994cited by this paper
• Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

  1994cited by this paper
• Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits

  1994cited by this paper
• Recent advances in the molecular biology of dopamine receptors.

  1993cited by this paper
• L-dopa and frontal cognitive function in Parkinson's disease.

  1993cited by this paper
• Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.

  1993cited by this paper
• Slowing of information processing in Parkinson's disease.

  1993cited by this paper
• Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys

  1992cited by this paper
• Parkinson's disease in twins studied with 18F‐dopa and positron emission tomography

  1992cited by this paper
• Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa.

  1992cited by this paper
• Studies of interference in serial verbal reactions.

  1992cited by this paper
• Positron emission tomography in degenerative disorders of the dopaminergic system

  1992cited by this paper
• The medial temporal lobe memory system

  1991cited by this paper
• The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

  1991cited by this paper
• Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

  1991cited by this paper
• Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.

  1991cited by this paper
• Cognitive change following MPTP exposure

  1990cited by this paper
• The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

  1990cited by this paper
• The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

  1990cited by this paper
• Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

  1989cited by this paper
• 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.

  1988cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Cognitive performance in early Parkinson's disease

  1986cited by this paper
• Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology

  1986cited by this paper
• Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

  1986cited by this paper
• Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease

  1986cited by this paper
• Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow.

  1986cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations

  1985cited by this paper
• Intellectual changes in patients with MPTP‐induced parkinsonism

  1985cited by this paper
• Cognitive deficits in the early stages of Parkinson's disease.

  1983cited by this paper
• Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

  1983cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, Third Edition

  1980cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• An inventory for measuring depression.

  1961cited by this paper

• The Caudate Nucleus Exhibits Distinct Pathology and Cell Type-Specific Responses Across Alzheimer’s Disease

  2026cites this paper
• Computational modeling of prefrontal cortex-basal ganglia-thalamus loops associated with Parkinson’s disease dementia

  2025cites this paper
• Cognitive effects of a single dose of methylphenidate in Parkinson's disease patients using electrophysiological measures.

  2025cites this paper
• Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation

  2025cites this paper
• Modelling cholinergic and dopaminergic function over time in Parkinson’s disease with and without GBA1 variants

  2025cites this paper
• Striatal dopamine synthesis capacity in Parkinson’s disease: Effects of age, sex, and body mass index in a large [18F]fluorodopa PET cohort

  2025cites this paper
• Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease

  2024cites this paper
• Update on the Role of [18F]FDOPA PET/CT.

  2024cites this paper
• Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson’s Disease

  2024cites this paper
• Deficits in or Preservation of Basic Number Processing in Parkinson's Disease? A Registered Report

  2024cites this paper
• Alpha-synuclein-induced nigrostriatal degeneration and pramipexole treatment disrupt frontostriatal plasticity

  2024cites this paper
• Decline in striatal binding ratio associated with accelerated decline in performance on symbol digit modality but not MoCA in Parkinson’s Disease Psychosis

  2024cites this paper
• Striatal dopamine transporter uptake, parkinsonism and cognition in Alzheimer's disease

  2023cites this paper
• Abnormalities of cerebral blood flow and the regional brain function in Parkinson’s disease: a systematic review and multimodal neuroimaging meta-analysis

  2023cites this paper
• Elevated serum platelet count inhibits the effects of brain functional changes on cognitive function in patients with mild cognitive impairment: A resting-state functional magnetic resonance imaging study

  2023cites this paper
• A multiple hits hypothesis for memory dysfunction in Parkinson disease

  2023cites this paper
• Slowing of EEG waves correlates with striatal [18F]fluorodopa PET/CT uptake and executive dysfunction in Parkinson's disease

  2023cites this paper
• Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease

  2023cites this paper
• In vivo18F-DOPA PET imaging identifies a dopaminergic deficit in a rat model with a G51D α-synuclein mutation

  2022cites this paper
• Defining the unknowns for cell therapies in Parkinson's disease

  2022cites this paper
• Developments in the mechanistic understanding and clinical application of deep brain stimulation for Parkinson’s disease

  2022cites this paper
• Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson’s Disease

  2022cites this paper
• Nigral pathology contributes to microstructural integrity of striatal and frontal tracts in Parkinson’s disease

  2022cites this paper
• Caudate-anchored cognitive connectivity pursuant to orthostatic hypotension in early Parkinson's disease

  2022cites this paper
• Management of psychiatric and cognitive complications in Parkinson’s disease

  2022cites this paper
• Assessment of progression of Parkinson’s disease using magnetic resonance morphometry

  2022cites this paper
• Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease

  2021cites this paper
• The correlation of non-motor symptoms and sleep on balance in Parkinson’s disease patients with normal cognition and mild cognitive impairment

  2021cites this paper
• Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

  2021cites this paper
• The Impact of Parkinson’s Disease on Postural Control in Older People and How Sex can Mediate These Results: A Systematic Review

  2021cites this paper
• Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies

  2021cites this paper
• Parkinsonism

  2021cites this paper
• Vision, attention, and driving.

  2021cites this paper
• Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson’s disease

  2021cites this paper
• Striatal dopamine correlates to memory and attention in Parkinson's disease.

  2021influential citation
• Deficits in or preservation of basic number processing in Parkinson’s disease? A registered report

  2021cites this paper
• Neural correlates of self‐awareness of cognitive deficits in non‐demented patients with Parkinson's disease

  2021cites this paper
• The Relationship Between the Striatal Dopaminergic Neuronal and Cognitive Function With Aging

  2020cites this paper
• Graph theory analysis of the dopamine D2 receptor network in Parkinson’s disease patients with cognitive decline

  2020cites this paper
• Processing speed is related to striatal dopamine transporter availability in Parkinson's disease

  2020cites this paper
• Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects

  2020cites this paper
• Functional neuroimaging evidence supporting the dual syndrome hypothesis of cognitive impairment in Lewy body disease

  2020cites this paper
• Association of Coffee, Decaffeinated Coffee and Caffeine Intake from Coffee with Cognitive Performance in Older Adults: National Health and Nutrition Examination Survey (NHANES) 2011–2014.

  2020cites this paper
• PET imaging of dopamine release in the frontal cortex of manganese‐exposed non‐human primates

  2019cites this paper
• The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males

  2019cites this paper
• Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: a study with positron emission tomography

  2019cites this paper
• Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)

  2019cites this paper
• Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia

  2019cites this paper
• The biology of cognitive decline and reduced survival in Parkinson disease : prognostic factors in a population-based cohort

  2019cites this paper
• Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.

  2019cites this paper
• NEUROPSYCHOLOGICAL CORRELATES OF STRIATAL DOPAMINERGIC DYSFUNCTION IN PARKINSON’S DISEASE

  2019influential citation
• Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification.

  2019cites this paper
• Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.

  2019cites this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cites this paper
• An Effect of Chronic Stress on Prospective Memory via Alteration of Resting-State Hippocampal Subregion Functional Connectivity

  2019cites this paper
• Clinical implications of early caudate dysfunction in Parkinson’s disease

  2019cites this paper
• Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease

  2019cites this paper
• Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

  2019cites this paper
• Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson’s disease: a detailed PET analysis of 12 striatal subregions

  2018cites this paper
• PET Molecular Imaging in Familial Parkinson's Disease.

  2018cites this paper
• Neuroprotective Role of N-acetylcysteine against Learning Deficits and Altered Brain Neurotransmitters in Rat Pups Subjected to Prenatal Stress

  2018cites this paper
• Cognitive Impairment and Dementias.

  2018cites this paper
• Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia

  2018cites this paper
• Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.

  2018cites this paper
• Motor cognition in patients treated with subthalamic nucleus deep brain stimulation: Limits of compensatory overactivity in Parkinson's disease

  2018cites this paper
• Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

  2018cites this paper
• Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

  2017cites this paper
• Imaging the Nonmotor Symptoms in Parkinson's Disease.

  2017cites this paper
• Striatal dopamine in Parkinson disease: A meta‐analysis of imaging studies

  2017cites this paper
• Cognitive impairment in progressive supranuclear palsy is associated with tau burden

  2017cites this paper
• Frontal-subcortical defects correlate with task switching deficits in Parkinson’s disease

  2017cites this paper
• The Nonmotor Features of Parkinson's Disease.

  2017cites this paper
• Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson’s Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task

  2017cites this paper
• Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease

  2017cites this paper
• Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson’s patients

  2017cites this paper
• Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers

  2017cites this paper
• Serotonin transporter binding and motor onset of Parkinson's disease in asymptomatic LRRK2 mutation carriers: a cross-sectional study

  2017cites this paper
• Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson's disease dementia.

  2017cites this paper
• Association between striatal dopamine D2/D3 receptors and brain activation during visual attention: effects of sleep deprivation

  2016cites this paper
• Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment

  2016cites this paper
• Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson’s Disease Patients Taking Dopaminergic Medication

  2016cites this paper
• Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

  2016cites this paper
• Effets de la stimulation magnétique transcrânienne dans la maladie de Parkinson avec déficits cognitifs légers

  2016cites this paper
• Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies

  2016cites this paper
• in Parkinson Disease Longitudinal Study of Gray Matter Changes

  2015cites this paper
• Longitudinal assessment of neural activity in Parkinson’s disease with mild cognitive impairment using task based fMRI

  2015cites this paper
• Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease.

  2015cites this paper
• Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study

  2015influential citation
• Dopamine signals and physiological origin of cognitive dysfunction in Parkinson's disease

  2015cites this paper
• Longitudinal Study of Gray Matter Changes in Parkinson Disease

  2015cites this paper
• Brain 18F-DOPA PET and cognition in de novo Parkinson’s disease

  2015influential citation
• Anterior cingulate dopamine turnover and behavior change in Parkinson’s disease

  2015cites this paper
• Neural correlates of local contextual processing across stimulus modalities and patient populations.

  2015cites this paper
• Parkinson's Disease—Related Spatial Covariance Pattern Identified with Resting-State Functional MRI

  2015cites this paper
• Dopaminergic correlates of metabolic network activity in Parkinson's disease

  2015cites this paper
• Motor loop dysfunction causes impaired cognitive sequencing in patients suffering from Parkinson's disease.

  2015cites this paper
• Imaging Acute NeurologicDisease: Parkinsonism

  2014cites this paper
• A dual‐tracer study of extrastriatal 6‐[18F]fluoro‐m‐tyrosine and 6‐[18F]‐fluoro‐l‐dopa Uptake in Parkinson's disease

  2014cites this paper
• Effects of the adenosine A2A receptor antagonist on cognitive dysfunction in Parkinson's disease.

  2014cites this paper
• The Role of Dynamin Like Protein 1 in Parkinson's Disease

  2014cites this paper